Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 3 (1)
P 4 (1)

Trial Status

Not Yet Recruiting3
Recruiting2
Unknown1

Clinical Trials (6)

Showing 6 of 6 trials
NCT07516769Phase 3RecruitingPrimary

Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

NCT07460739Not ApplicableNot Yet RecruitingPrimary

Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis

NCT07469540Not ApplicableRecruiting

Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arthritis

NCT07321340Not ApplicableNot Yet RecruitingPrimary

Insole Optimization for Rheumatoid Arthritis Patients

NCT06687551Phase 4Not Yet RecruitingPrimary

JAK Inhibitor Dose TAPering Strategy Study

NCT03713736Not ApplicableUnknown

Papillomavirus Load in Rheumatic Inflammatory Diseases

Showing all 6 trials

Research Network

Activity Timeline